scispace - formally typeset
E

Edward Giovannucci

Researcher at Harvard University

Publications -  1819
Citations -  202335

Edward Giovannucci is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 206, co-authored 1671 publications receiving 179875 citations. Previous affiliations of Edward Giovannucci include University of California, San Francisco & American Cancer Society.

Papers
More filters
Journal ArticleDOI

Evidence for a U-Shaped Relationship Between Prehospital Vitamin D Status and Mortality: A Cohort Study

TL;DR: Analysis of 24 094 adult patients showed that 25(OH)D levels less than 20 ng/mL and 60 ng/ mL or greater before hospitalization were associated with an increased odds of 90-day mortality, which raises the issue of potential harm from high serum 25-hydroxyvitamin D levels, provide a rationale for an upper limit to supplementation, and emphasize the need for caution in the use of extremely high doses of vitamin D among patients.
Journal ArticleDOI

Dietary choline and betaine and the risk of distal colorectal adenoma in women

TL;DR: The positive association between choline intake and colorectal adenoma that was observed could represent effects of other components in the foods from which choline was derived and should be investigated further.
Journal ArticleDOI

Circulating prediagnostic interleukin‐6 and C‐reactive protein and prostate cancer incidence and mortality

TL;DR: The study suggests that IL‐6 may potentially be involved in the development or progression of prostate cancer, and assesses interactions between inflammatory markers and body mass index and plasma levels on prostate cancer outcomes.
Journal ArticleDOI

Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study

TL;DR: Advanced periodontitis was associated with a 2.5-fold increase in smoking-related cancers among never smokers, and may impact cancer risk through system immune dysregulation.